Labetamac Tablet contains Labetalol 100 mg, a combined alpha- and beta-adrenergic receptor blocker used primarily in the management of hypertension. By inhibiting both alpha-1 and beta-adrenergic receptors, Labetalol reduces peripheral vascular resistance without significantly affecting cardiac output or heart rate, making it effective in controlling elevated blood pressure. It is indicated for the treatment of essential hypertension, including hypertensive emergencies and urgencies, and is particularly useful in patients with concomitant conditions such as ischemic heart disease or heart failure. Labetalol’s dual mechanism allows for vasodilation and decreased systemic vascular resistance, leading to improved blood flow and reduced cardiac workload. The drug is administered orally, with dosing individualized based on patient response and clinical condition. Common adverse effects include dizziness, fatigue, nausea, and headache, while serious side effects may involve bradycardia, hypotension, and bronchospasm, especially in patients with reactive airway disease. Caution is advised in patients with asthma, severe bradycardia, or heart block. Labetamac Tablet should be used under medical supervision with regular monitoring of blood pressure and heart rate to optimize therapeutic outcomes and minimize risks.